Study on the Safety and Effectiveness of a Biodegradable Patent Foramen Ovale Occluder System

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 258 participants.

Also called NCT07300358

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 258 participants (planned count) (from the registry)
Sponsor
Shanghai Lingsi Medical Technology Co., Ltd. (from the registry)
Registry
  • NCT NCT07300358
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07300358. Randomized; triple masking; primary purpose prevention. Start 2025-12-30 (anticipated); primary completion 2027-06-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study on the Safety and Effectiveness of a Biodegradable Patent Foramen Ovale Occluder System
Acronym
BIOCLOSE-PFO
Condition
Cardiovascular Diseases
Condition
Cardiovascular Abnormality
Condition
Heart Defects, Congenital
Condition
Heart Septal Defects
Condition
Heart Septal Defects, Atrial
Condition
Foramen Ovale, Patent
Condition
Stroke, Ischemic
Condition
Stroke (CVA) or TIA (transient ischemic attack)
Intervention (Device)
Active Comparator
Intervention (Device)
Experimental
Lead sponsor
Shanghai Lingsi Medical Technology Co., Ltd. (class: other)

Record details

Record id
cardio:ct-nct07300358
Content hash
90aab07dd204c55da4a7b4370730e2b8fecf4dbc567ac7fbf2e1ae00e3ef1abb